Rose Chang

Vice President
Rose Chang



Sc.D., epidemiology, and M.S., biostatistics, Harvard T.H. Chan School of Public Health; M.S.P.H, epidemiology, Rollins School of Public Health of Emory University; B.Sc.H., life sciences, Queen’s University

Summary of Experience

Dr. Chang specializes in epidemiology and outcomes research, including the application of advanced methods to generate real-world evidence (RWE) on unmet needs, treatment patterns, and drug safety and effectiveness. She has experience working across therapeutic areas with various types of health care data, including administrative insurance claims, electronic medical records, medical chart reviews, clinical trials, patient and physician surveys, and patient registries. Dr. Chang has provided regulatory and strategic consulting on RWE generation and conducted several RWE studies to contextualize clinical trial results for regulatory new drug application (NDA) and supplemental new drug application (sNDA) submissions. Her work has been presented at scientific conferences and published in several peer-reviewed medical journals. Prior to joining Analysis Group, Dr. Chang worked as a research trainee and a teaching assistant at the Harvard T.H. Chan School of Public Health.

Selected Publishing